fda semaglutide news says Wegovy and Ozempic shortage resolved; Hims & Hers stock falls Live Updates on Semaglutide's Current

My fasting blood sugar was also high

Both agents lower blood glucose through different mechanisms, and their simultaneous use could theoretically increase the risk of hypoglycemia, particularly in patients taking other antidiabetic medications such as insulin or sulfonylureas

Fatigue is a common complaint during the early weeks of GLP-1 treatment, particularly as calorie intake drops and the body adjusts to lower food volume

D.Moreno-IndiasI.TinahonesF

Specifically, this peptide targets three crucial receptors involved in metabolic function: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor